🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested
The ending of this study is to describe the effect of febrile neutropenia o...
Status
Completed
Location
Institut Sainte Catherine
Start Date
2010-06
Trial ID
NCT01268878
In second line with advanced or recurrent biliary tract cancer refractory t...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2015-07-29
Trial ID
NCT03464968
Treatments Being Tested
The purpose of this study is to determine whether intraperitoneal immunothe...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02976142
Treatments Being Tested
This is a randomized, multicenter, phase III trial comparing induction chem...
Status
Terminated
Location
Hôpital de la Pitié-Salpétrière
Start Date
2009-01
Trial ID
NCT00828386
Treatments Being Tested
The purpose of this trial is to investigate the efficacy of cetuximab in co...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00122460
The primary purpose of this study is to help answer the following research ...
Status
Completed
Location
Highlands Oncology Group
Start Date
2010-04
Trial ID
NCT01099358
Treatments Being Tested
The purpose of this study is to determine the safety and maximum tolerated ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
1997-10
Trial ID
NCT00139243
Treatments Being Tested